MRPS24: A Potential Drug Target and Biomarker (G64951)

Target Name: MRPS24

NCBI ID: G64951

MRPS24

MRPS24: A Potential Drug Target and Biomarker

MRP (MutL-RISC Pathway) is a protein that plays a crucial role in the regulation of gene expression and cell signaling. It is a transmembrane protein that contains two subunits, MRP1 and MRP2. MRP2 is a 24kDa protein that is known to regulate gene expression and contribute to the development of various diseases, including cancer.

The MRP2 protein has been identified as a potential drug target in the field of cancer, due to its involvement in the regulation of cell signaling pathways that are often disrupted in cancer cells. In addition, the MRP2 protein has also been shown to be overexpressed in various types of cancer, which may contribute to its potential as a therapeutic target.

The MRP2 protein is known to have multiple functions, including the regulation of cell adhesion, cell signaling, and cell cycle progression. It is involved in the regulation of several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

One of the functions of the MRP2 protein is the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. The MRP2 protein is involved in the regulation of cell adhesion by controlling the activity of several adhesion molecules, including cadherins and immunoglobulin adhesion molecules.

The MRP2 protein is also involved in the regulation of cell signaling pathways. It is a negative regulator of the TGF-β pathway, which is a well-known signaling pathway that is involved in cell growth, differentiation, and cancer development. The TGF-β pathway is often disrupted in cancer cells, and the MRP2 protein may contribute to the regulation of this pathway in cancer cells.

The MRP2 protein is also involved in the regulation of cell cycle progression. It is a negative regulator of the p21 (CDK4) gene, which encodes the tumor suppressor protein p21. The p21 gene is often disrupted in cancer cells, and the MRP2 protein may contribute to the regulation of this gene in cancer cells.

In addition to its functions in cell adhesion and cell signaling, the MRP2 protein is also involved in the regulation of inflammation. It is a strong predictor of cancer progression and has been shown to be involved in the regulation of immune cell function.

The MRP2 protein has also been shown to be overexpressed in various types of cancer, including breast, ovarian, and colorectal cancers. This may contribute to its potential as a therapeutic target in cancer therapy.

In conclusion, the MRP2 protein is a potential drug target and biomarker in cancer. Its functions in cell adhesion, cell signaling, and cell cycle progression, as well as its involvement in the regulation of inflammation, make it an attractive target for cancer therapy. Further research is needed to fully understand the mechanisms of the MRP2 protein in cancer and to develop effective treatments.

Protein Name: Mitochondrial Ribosomal Protein S24

The "MRPS24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets